IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Logos Global Management LP

Q1 2026 Holdings

Filed 2026-05-15 | 66 holdings | $2.0B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Revolution Medicines Inc(RVMD)COM76155X100$194.5M2,000,0009.7%
Erasca Inc(ERAS)COM29479A108$180.4M11,150,0009.0%
Ideaya Biosciences Inc(IDYA)COM45166A102$115.0M3,450,0005.7%
Praxis Precision Medicines I(PRAX)COM NEW74006W207$91.8M285,0004.6%
Centessa Pharmaceuticals PLC(CNTA)SPONSORED ADS152309100$84.4M2,125,0004.2%
Terns Pharmaceuticals Inc(TERN)COM880881107$79.1M1,500,0003.9%
Abivax SA(ABVX)SPONSORED ADS00370M103$75.2M675,0003.8%
Tango Therapeutics Inc(TNGX)COM87583X109$62.8M3,000,0003.1%
Cytokinetics Inc(CYTK)COM NEW23282W605$57.7M875,0002.9%
Olema Pharmaceuticals Inc(OLMA)COM68062P106$47.8M3,208,8752.4%
United Therapeutics Corp del(UTHR)COM91307C102$47.4M80,0002.4%
Immunocore Hldgs PLC(IMCR)ADS45258D105$45.2M1,500,0002.3%
Madrigal Pharmaceuticals Inc(MDGL)COM558868105$44.5M85,0002.2%
Rhythm Pharmaceuticals Inc(RYTM)COM76243J105$39.1M450,0002.0%
CG Oncology Inc(CGON)COM156944100$38.9M575,0001.9%
Maze Therapeutics Inc(MAZE)COM578784100$36.9M1,235,0001.8%
Biogen Inc(BIIB)COM09062X103$36.7M200,0001.8%
Disc Medicine Inc(IRON)COM254604101$35.8M560,0001.8%
Dianthus Therapeutics Inc(DNTH)COM252828108$33.6M400,0001.7%
Ocular Therapeutix Inc(OCUL)COM67576A100$32.6M3,850,0001.6%
Tyra Biosciences Inc(TYRA)COM90240B106$32.6M850,0001.6%
Trevi Therapeutics Inc(TRVI)COM89532M101$28.6M2,400,0001.4%
Moonlake Immunotherapeutics(MLTX)CLASS A ORD61559X104$28.0M1,500,0001.4%
Immunovant Inc(IMVT)COM45258J102$26.7M1,075,0001.3%
Terns Pharmaceuticals Inc(TERN)CallCOM880881107$26.4M500,0001.3%
Xenon Pharmaceuticals Inc(XENE)COM98420N105$26.2M450,0001.3%
Arcus Biosciences Inc(RCUS)COM03969F109$25.9M1,200,0001.3%
Dyne Therapeutics Inc(DYN)COM26818M108$25.4M1,400,0001.3%
Structure Therapeutics Inc(GPCR)SPONSORED ADS86366E106$24.1M500,0001.2%
LB Pharmaceuticals Inc(LBRX)COM SHS50180M108$22.6M915,0001.1%
Enliven Therapeutics Inc(ELVN)COM29337E102$21.2M540,0001.1%
Design Therapeutics Inc(DSGN)COM25056L103$20.7M1,950,0001.0%
Enliven Therapeutics Inc(ELVN)CallCOM29337E102$19.6M500,0001.0%
Minerva Neurosciences Inc(NERV)COM NEW603380205$19.4M3,215,0001.0%
Newamsterdam Pharma Company(NAMS)ORDINARY SHARESN62509109$19.2M600,0001.0%
Mirum Pharmaceuticals Inc(MIRM)COM604749101$18.5M200,0000.9%
Vaxcyte Inc(PCVX)COM92243G108$17.4M300,0000.9%
Acadia Pharmaceuticals Inc(ACAD)COM004225108$16.7M750,0000.8%
Compass Therapeutics Inc(CMPX)COM20454B104$16.7M3,150,0000.8%
Avalo Therapeutics Inc(AVTX)CallCOM NEW05338F306$14.9M1,000,0000.7%
Celldex Therapeutics Inc New(CLDX)COM NEW15117B202$14.3M450,0000.7%
Janux Therapeutics Inc(JANX)COM47103J105$13.9M1,000,0000.7%
VOR Biopharma Inc(VOR)COM NEW929033207$13.4M750,0000.7%
Alkermes PLC(ALKS)SHSG01767105$12.4M350,0000.6%
Oric Pharmaceuticals Inc(ORIC)COM68622P109$12.0M950,0000.6%
Immix Biopharma Inc(IMMX)COM45258H106$11.2M1,225,0000.6%
Tenax Therapeutics Inc(TENX)COM NEW88032L605$10.0M625,0000.5%
Amylyx Pharmaceuticals Inc(AMLX)COM03237H101$9.7M700,0000.5%
Crescent Biopharma Inc.(CBIO)COMG2545C104$8.9M482,5000.4%
Soleno Therapeutics Inc(SLNO)COM834203309$8.4M250,0000.4%
Page 1 of 2Next